Antidepressant Use in
Children, Adolescents, and Adults
The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).
List of Antidepressant Drugs with Medication Guides
For more information on some of these drugs, please see the Index to Drug-Specific Information.
PDF requires the free Adobe
Back to Drug Information
Date created: March 22, 2004, updated May 2, 2007